Ouvrages publiés en collaboration (1)
Articles dans des revues avec comité de lecture (68)
1.
Schoenauen, L., Stubbe, F. X., Van Gestel, D., Penninckx, S., & Heuskin, A.-C. (2024). C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect. Clinical and Translational Radiation Oncology, 45, 100712. doi:10.1016/j.ctro.2023.1007122.
De Caluwe, A., Romano, E., Poortmans, P., Gombos, A., Agostinetto, E., Marta, G. N., Denis, Z., Drisis, S., Vandekerkhove, C., Desmet, A., Philippson, C., Craciun, L., Veys, I., Larsimont, D., Paesmans, M., Van Gestel, D., Salgado, R., Sotiriou, C., Piccart-Gebhart, M., Ignatiadis, M., & Buisseret, L. (2023). First-in-human study of SBRT and adenosine pathway blockade to potentiate the benefit of immunochemotherapy in early-stage luminal B breast cancer: results of the safety run-in phase of the Neo-CheckRay trial. Journal for ImmunoTherapy of Cancer, 11(12). doi:10.1136/jitc-2023-0072794.
Burghelea, M., Bakkali Tahiri, J., Dhont, J., Kyndt, M., Gulyban, A., Szkitsak, J., Bogaert, E., Van Gestel, D., & Reynaert, N. (2023). Results of a multicenter 4D computed tomography quality assurance audit: Evaluating image accuracy and consistency. Physics and Imaging in Radiation Oncology, 28, 100479. doi:10.1016/j.phro.2023.1004795.
Sabbah, M., Najem, A., Vanderkerkhove, C., Kert, F., Jourani, Y., Journe, F., Awada, A., Van Gestel, D., Ghanem, G. E., & Krayem, M. (2023). The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma. Frontiers in medicine, 10. doi:10.3389/fmed.2023.11499186.
Mootassim-Billah, S., Schoentgen, J., De Bodt, M. M., Roper, N., Digonnet, A., Le Tensorer, M., Van Nuffelen, G., & Van Gestel, D. (2023). Acoustic Analysis of Voluntary Coughs, Throat Clearings, and Induced Refexive Coughs in a Healthy Population. Dysphagia.7.
Iliadi Anagnostaki, C., Verset, L., Bouchart, C., Martinive, P., Van Gestel, D., & Krayem, M. (2023). The current understanding of the immune landscape relative to radiotherapy across tumor types. Frontiers in Immunology, 14. doi:10.3389/fimmu.2023.11486928.
Benkhaled, S., Peters, C., Jullian, N., Arsenijevic, T., Navez, J., Van Gestel, D., Moretti, L., Van Laethem, J.-L., & Bouchart, C. (2023). Combination, Modulation and Interplay of Modern Radiotherapy with the Tumor Microenvironment and Targeted Therapies in Pancreatic Cancer: Which Candidates to Boost Radiotherapy? Cancers, 15(3), 768. doi:10.3390/cancers150307689.
Dragan, T., Van Gossum, A., Duprez, F., Lalami, Y., Lefebvre, Y., Mootassim-Billah, S., Beauvois, S., Gulyban, A., Vandekerkhove, C., Boegner, P., Paesmans, M., Ameye, L., Digonnet, A., Quiriny, M., Dequanter, D., Lipski, S., Willemse, E., Rodriguez, A., Carlot, S., Karaca, Y., Lemort, M., Emonts, P., Al Wardi, C., & Van Gestel, D. (2022). Patient-reported outcomes in terms of swallowing and quality of life after prophylactic versus reactive percutaneous endoscopic gastrostomy tube placement in advanced oropharyngeal cancer patients treated with definitive chemo-radiotherapy: Swall PEG study. Current controlled trials. Cardiovascular medicine, 23(1). doi:10.1186/s13063-022-06991-610.
Philippson, C., Larsen, S., Simon, S., Vandekerkhove, C., De Caluwé, A., Van Gestel, D., Chintinne, M., Veys, I., De Neubourg, F., Noterman, D., Roman, M.-M., Nogaret, J.-M., & Desmet, A. (2022). Intraoperative electron radiotherapy in early invasive ductal breast cancer: 6-year median follow-up results of a prospective monocentric registry. Breast cancer research, 24(1). doi:10.1186/s13058-022-01582-411.
Manderlier, M., Navez, J., Hein, M., Engelholm, J. L., Closset, J., Bali, M. A., Van Gestel, D., Moretti, L., Van Laethem, J.-L., & Bouchart, C. (2022). Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation. Cancers (Basel), 14(23). doi:10.3390/cancers14235730